Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021Azalea Thomson, Deepa Dongarwar, Theresa A. McHugh et al.|The Lancet Haematology|2023Cited by 674
Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021Tiffany K. Gill, Belay Desye, Manasi Murthy Mittinty et al.|The Lancet Rheumatology|2023Cited by 370
Deep Intronic <i>FGF14</i> GAA Repeat Expansion in Late-Onset Cerebellar AtaxiaDavid Pellerin, Matthis Synofzik, Matt C. Danzi et al.|New England Journal of Medicine|2022Cited by 243
Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021Hannah Han, Pietro Ferrara, Yaser Mohammed Al‐Worafi et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 63
TEFM variants impair mitochondrial transcription causing childhood-onset neurological diseaseLindsey Van Haute, Rita Horváth, Emily O’Connor et al.|Nature Communications|2023Cited by 30